Published: Oct 2015
ACE Report #10382
Ace Report Cover Cannabis

Dronabinol does not cause metabolic disturbances in managing chronic neuropathy pain

Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

A 4-week pilot study with the cannabinoid receptor agonist dronabinol and its effect on metabolic parameters in a randomized trial

Clin Ther. 2015 Oct 1;37(10):2267-74. doi: 10.1016/j.clinthera.2015.07.023

Contributing Authors: L Bayman J Valestin A Rizvi-Toner R Schey ZW Reichenbach J Sloan

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.